Mar 302020
 

By Talent4Boards Team

Talent4Boards - Great Talent builds Great Boards

– USA, MA – ElevateBio, LLC, a Cambridge-based creator and operator of a portfolio of innovative cell and gene therapy companies, today announced it has closed a $170-million Series B financing that will support and accelerate the company's next phase of growth. New investors, The Invus Group, Surveyor Capital, EDBI, ...

ElevateBio adds Germano Giuliani to its Board along with raising $170m Series B financing to support and accelerate next phase of growth

ElevateBio adds Germano Giuliani to its Board along with raising $170m Series B financing to support and accelerate next phase of growth

From:: ElevateBio adds Germano Giuliani to its Board along with raising $170m Series B financing to support and accelerate next phase of growth

Sorry, the comment form is closed at this time.